Succinimidyl carbamate derivatives from N-protected α-amino acids and dipeptides-synthesis of ureidopeptides and oligourea/peptide hybrids

European Journal of Organic Chemistry

Volumn , Issue 15, 2007, Pages 2511-2525

  Fischer, Lucile ^a   Semetey, Vincent ^a,d   Lozano, Jose Manuel ^b   Schaffner, Arnaud Pierre ^a,e   Briand, Jean Paul ^a   Didierjean, Claude ^c   Guichard, Gilles ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c UNIVERSITÉ DE LORRAINE   (France)

^d INSTITUT CURIE   (France)

^e EMC MICROCOLLECTIONS GMBH   (Germany)

Author keywords

Oligomers; Peptides; Peptidomimetics; Solid phase synthesis; Urea

Indexed keywords

EID: 34250787062     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200601010     Document Type: Article

References (103)

1. a) A. F. Spatola in Chemistry and Biochemistry of Amino acids, Peptides and Proteins (Ed.: B. Weinstein), Marcel Dekker Inc., New York, 1983; vol. 7, pp. 267-357;
2. b) T. K. Sawyer in Peptide-Based Drug Design Controlling Transport and Metabolism (Eds.: M. D. Taylor, G. L. Amidorn), Oxford University Press, New York, 1995, pp. 332-422.
3. a) G. Guichard in Pseudopeptides in Drug Development (Eds.: P. E. Nielsen), Wiley-VCH, Weinheim, Germany, 2004, 33-120;
4. b) D. Seebach, A. K. Beck, D. J. Bierbaum, Chem. Biodiversity 2004, 1, 1111-1239;
5. c) R. P. Cheng, S. H. Gellman, W. F. DeGrado, Chem. Rev. 2001, 101, 3219-3232;
6. d) D. J. Hill, M. J. Mio, R. B. Prince, T. S. Hughes, J. S. Moore, Chem. Rev. 2001, 101, 3893-4011;
7. e) S. H. Gellman, Acc. Chem. Res. 1998, 31, 173-180;
8. f) D. Seebach, J. L. Matthews, Chem. Commun. 1997, 2015-2022.
9. a) J. A. Kritzer, O. M. Stephens, D. A. Guarracino, S. K. Reznik, A. Schepartz, Bioorg. Med. Chem. 2005, 13, 11-16;
10. b) J. A. Patch, A. E. Barron, Curr. Opin. Chem. Biol. 2002, 6, 872 877;
11. c) R. M. J. Liskamp, Angew. Chem. Int. Ed. Engl. 1994, 33, 633-636.
12. J. S. Nowick, Acc. Chem. Res. 1999, 32, 287-296 and references cited therein.
13. a) K. Burgess, D. S. Linthicum, H. Shin, Angew. Chem. Int. Ed. Engl. 1995, 34, 907-908;
14. b) K. Burgess, J. Ibarzo, D. S. Linthicum, D. H. Russell, H. Shin, A. Shitangkoon, R. Totani, A. J. Zhang, J. Am. Chem. Soc. 1997, 119, 1556-1564;
15. c) J. M. Kim, Y. Bi, S. J. Paikoff, P. G. Schultz, Tetrahedron Lett. 1996, 37, 5305-5308;
16. d) N. Tamilarasu, I. Huq, T. M. Rana, J. Am. Chem. Soc. 1999, 121, 1597-1598;
17. e) A. Boeijen, R. M. J. Liskamp, Eur. J. Org. Chem. 1999, 2127-2135;
18. f) G. Guichard, V. Semetey, C. Didierjean, A. Aubry, J. P. Briand, M. Rodriguez, J. Org. Chem. 1999, 64, 8702-8705;
19. g) G. Guichard, V. Semetey, M. Rodriguez, J. P. Briand, Tetrahedron Lett. 2000, 41, 1553-1557.
20. J. A. W. Kruijzer, D. J. Lefeber, R. M. J. Liskamp, Tetrahedron Lett. 1997, 38, 5335-5338.
21. J. M. Kim, T. E. Wilson, T. C. Norman, P. G. Schultz, Tetrahedron Lett. 1996, 37, 5309-5312.
22. For selected examples of cyclic ureas as enzyme inhibitors, see: a) P. Y. S. Lam, P. K. Jadhav, C. J. Eyerman, C. N. Hodge, Y. Ru, L. T. Bacheler, J. L. Meek, M. J. Otto, M. M. Rayner, Y. N. Wong, C.-H. Chang, P. C. Weber, D. A. Jackson, T. R. Sharpe, S. Erickson-Viitanen, Science 1994, 263, 380-384;
23. b) R. A. Galemmo Jr, T. P. Maduskuie, C. Dominguez, K. A. Rossi, R. M. Knabb, R. R. Wexler, P. F. Stouten, Bioorg. Med. Chem. Lett. 1998, 8, 2705-2710;
24. c) A. Bonnefoy, C. Dupuis-Hamelin, V. Steier, C. Delachaume, C. Seys, T. Stachyra, M. Fairley, M. Guitton, M. Lampilas, J. Antimicrob. Chemother. 2004, 54, 410-417;
25. d) S. F. Martin, B. C. Follows, P. J. Hergenrother, C. L. Franklin, J. Org. Chem. 2000, 65, 4509-4514.
26. For a selection of recent examples of N,N′-biarylureas as enzymes inhibitors, see: a) X. Du, E. Hansell, J. C. Engel, C. R. Caffrey, F. E. Cohen, J. H. McKerrow, Chem. Biol. 2000, 7, 733-742;
27. b) R. A. Porter, W. N. Chan, S. Coulton, A. Johns, M. S. Hadley, K. Widdowson, J. C. Jerman, S. J. Brough, M. Coldwell, D. Smart, F. Jewitt, P. Jeffrey, N. Austin, Bioorg. Med. Chem. Lett. 2001, 11, 1907-1910;
28. c) M. L. Curtin, R. R. Frey, H. R. Heyman, K. A. Sarris, D. H. Steinman, J. H. Holmes, P. F. Bousquet, G. A. Cunha, M. D. Moskey, A. A. Ahmed, L. J. Pease, K. B. Glaser, K. D. Stewart, S. K. Davidsen, M. R. Michaelides, Bioorg. Med. Chem. Lett. 2004, 14, 4505-4509;
29. d) C. J. Goodacre, S. M. Bromidge, D. Clapham, F. D. King, P. J. Lovell, M. Allen, L. P. Campbell, V. Holland, G. J. Riley, K. R. Starr, B. K. Trail, M. D. Wood, Bioorg. Med. Chem. Lett. 2005, 15, 4989-4993;
30. e) H. K. Rami, M. Thompson, G. Stemp, S. Fell, J. C. Jerman, A. J. Stevens, D. Smart, B. Sargent, D. Sanderson, A. D. Randall, M. J. Gunthorpe, J. B. Davis, Bioorg. Med. Chem. Lett. 2006, 16, 3287-3291.
31. 2 group by a urea linkage, see: a) A. P. Kozikowski, J. Zhang, F. Nan, P. A. Petukhov, E. Grajkowska, J. T. Wroblewski, T. Yamamoto, T. Bzdega, B. Wroblewska, J. H. Neale, J. Med. Chem. 2004, 47, 1729-1738;
32. b) M. J. Slater, E. M. Amphlett, D. M. Andrews, P. Bamborough, S. J. Carey, M. R. Johnson, P. S. Jones, G. Mills, N. R. Parry, D. O'N. Somers, A. J. Stewart, T. Skarzynski, Org. Lett. 2003, 5, 4627-4630;
33. c) A. P. Kozikowski, F. Nan, P. Conti, J. Zhang, E. Ramadan, T. Bzdega, B. Wroblewska, J. H. Neale, S. Pshenichkin, J. T. Wroblewski, J. Med. Chem. 2001, 44, 298-301;
34. d) N. A. Dales, R. S. Bohacek, K. A. Satyshur, D. H. Rich, Org. Lett. 2001, 3, 2313-2316.
35. For selected examples of intermolecular H-bonded molecular assemblies of acyclic ureas in the crystal, see a) W. Dannecker, J. Kopf, H. Rust, Cryst. Struct. Commun. 1979, 8, 429;
36. b) X. Zhao, Y.-L. Chang, F. W. Fowler, J. W. Lauher, J. Am. Chem. Soc. 1990, 112, 6627-6634;
37. c) M. C. Etter, Z. Urbanczyklipowska, M. Zia-Ebrahimi, T. W. Panunto, J. Am. Chem. Soc. 1990, 112, 8415-8426;
38. d) M. de Loos, J. van Esch, I. Stokroos, R. M. Kellogg, B. L. Feringa, J. Am. Chem. Soc. 1997, 119, 12675-12676;
39. e) P. S. Corbin, S. C. Zimmerman, P. A. Thiessen, N. A. Hawryluk, T. J. Murray, J. Am. Chem. Soc. 2001, 123, 10475-10488;
40. f) L. S. Shimizu, M. D. Smith, A. D. Hughes, K. D. Shimizu, Chem. Commun. 2001, 1592-1593;
41. g) M. Barboiu, G. Vaughan, A. Van der Lee, Org. Lett. 2003, 5, 3073-3076;
42. h) M. Alajarin, A. Pastor, R. A. Orenes, J. W. Steed, R. Arakawa, Chem. Eur. J. 2004, 10, 1383-1397.
43. For self assembly of linear peptidyl ureas, see a) D. Ranganathan, S. Kurur, K. P. Madhusudanan, I. L. Karle, Tetrahedron Lett. 1997, 38, 4659-4662;
44. b) T. Moriuchi, T. Tamura, T. Hirao, J. Am. Chem. Soc. 2002, 124, 9356-9357.
45. For peptidomimetic macrocyclic/heterocyclic urea-based systems that self-organize into hollow tubular structures, see ureas in the (Z,Z) conformation: a) D. Ranganathan, C. Lakshmi, I. Karle, J. Am. Chem. Soc. 1999, 121, 6103-6107;
46. b) V. Semetey, C. Didierjean, J.-P. Briand, A. Aubry, G. Guichard, Angew. Chem. Int. Ed. 2002, 41, 1895-1898;
47. with ureas in the (E,E) conformation: c) A.-P. Schaffner, G. Lena, S. Roussel, A. Wawrezinieck, A. Aubry, J.-P. Briand, C. Didierjean, G. Guichard, Chem. Commun. 2006, 4069-4071.
48. a) A. Violette, M. C. Averlant-Petit, V. Semetey, C. Hemmerlin, R. Casimir, R. Graff, M. Marraud, J.-P. Briand, D. Rognan, G. Guichard, J. Am. Chem. Soc. 2005, 127, 2156-2164;
49. b) C. Hemmerlin, M. Marraud, D. Rognan, R. Graff, V. Semetey, J. P. Briand, G. Guichard, Helv. Chim. Acta 2002, 85, 3692-3711;
50. c) V. Semetey, D. Rognan, C. Hemmerlin, R. Graff, J.-P. Briand, M. Marraud, G. Guichard, Angew. Chem. Int. Ed. 2002, 41, 1893-1895.
51. A. Violette, S. Fournel, K. Lamour, O. Chaloin, B. Frisch, J.-P. Briand, H. Monteil, G. Guichard, Chem. Biol. 2006, 13, 531-538.
52. G. L. Tritsch, D. W. Wooley, J. Am. Chem. Soc. 1960, 82, 2787-2793.
53. a) R. E. Vegner, G. I. Chipens, J. Gen. Chem. USSR (Engl. Transl.) 1975, 45, 431-434;
54. b) Y. E. Antsan, G. I. Chipens, Sov. J. Bioorg. Chem. (Engl. Transl.) 1975, 1, 998-1004;
55. c) Y. E. Antsan, N. A. Makarova, G. I. Chipens, Sov. J. Bioorg. Chem. (Engl. Transl.) 1982, 3, 185-190.
56. K. Kawasaki, M. Maeda, J. Watanabe, H. Kaneto, Chem. Pharm. Bull. 1988, 36, 1766-1771.
57. M. Rodriguez, P. Dubreuil, J. P. Bali, J. Martinez, J. Med. Chem. 1987, 30, 758-763.
58. a) A. C. Myers, J. A. Kowalski, M. A. Lipton, Bioorg. Med. Chem. Lett. 2004, 14, 5219-5222;
59. b) B. S. Barth, A. C. Myers, M. A. Lipton, J. Pept. Res. 2005, 65, 352-354.
60. V. Guerlavais, D. Boeglin, D. Mousseaux, C. Oiry, A. Heitz, R. Deghenghi, V. Locatelli, A. Torsello, C. Ghe, F. Catapano, G. Muccioli, J. C. Galleyrand, J. A. Fehrentz, J. Martinez, J. Med. Chem. 2003, 46, 1191-1203.
61. Two crystal structures of geminal amino-ureas derived from Phe and Val have been reported by Chipens and coworkers: a) A. A. Kemme, Y. Y. Bleidelis, Y. E. Antsans, G. I. Chipens, Zh. Struckt. Khim. 1976, 17, 1132;
62. b) A. F. Mishnev, Y. Y. Bleidelis, Y. E. Antsans, G. I. Chipens, Zh. Struckt. Khim. 1979, 20, 154-157.
63. V. Semetey, C. Hemmerlin, C. Didierjean, A. P. Schaffner, A. G. Giner, A. Aubry, J. P. Briand, M. Marraud, G. Guichard, Org. Lett. 2001, 3, 3843-3846.
64. While this manuscript was in preparation, Sureshbabu and coworkers reported the use of N-Fmoc-protected peptidyl isocyanates for the solution-phase synthesis of ureidopeptides V. V. Sureshbabu, B. S. Patil, R. Venkataramanarao, J. Org. Chem. 2006, 71, 7697-7705.
65. a) G. Lena, E. Lallemand, A. Charlotte Grüner, J. Boeglin, S. Roussel, A.-P. Schaffner, A. Aubry, J.-F. Franetich, D. Mazier, I. Landau, J.-P. Briand, C. Didierjean, L. Rénia, G. Guichard, Chem. Eur. J. 2006, 12, 8498-8512;
66. b) P. Muller, G. Lena, S. Bezzine, E. Boilard, M. Lazdunski, G. Lambeau, G. Guichard, D. Rognan, J. Med. Chem. 2006, 49, 6768-6678.
67. N,N′-Diacylated 1,1-diaminoalkanes were first synthesized and used by Bergmann and Zervas in their "carbobenzoxy degradation" for polypeptide sequencing: M. Bergmann, L. Zervas, J. Biol. Chem. 1936, 113, 341-357.
68. a) M. Chorev, C. G. Wilson, M. Goodman, J. Am. Chem. Soc. 1977, 99, 8075-8076.
69. For reviews on PMRI, see a) M. Goodman, M. Chorev, Acc. Chem. Res. 1979, 12, 1-7;
70. b) M. Chorev, M. Goodman, Acc. Chem. Res. 1993, 26, 266-273;
71. c) M. D. Fletcher, M. M. Campbell, Chem. Rev. 1998, 98, 763-796.
72. Attempts to purify these carbamates by flash chromatography on silica gel often resulted in partial decomposition.
73. M. Chorev, S. A. MacDonald, M. Goodman, J. Org. Chem. 1984, 49, 821-827.
74. a) S. Terashima, K. K. Lee, S. Yamada, Chem. Pharm. Bull. 1969, 17, 2533-2539;
75. b) K. K. Lee, S. Terashima, K. Achiwa, S. Yamada, Chem. Pharm. Bull. 1969, 17, 2540-2547;
76. c) B. S. Axelsson, K. J. O'Toole, P. A. Spencer, D. W. Young, J. Chem. Soc., Perkin Trans. 1 1994, 807-815.
77. Peptide azides do not readily epimerize, but in certain cases they can lose optical purity during the peptide coupling particularly in the presence of excess base: a) F. Weygand, A. Prox, W. König, Chem. Ber. 1966, 99, 1451-1460;
78. b) P. Sieber, B. Riniker, M. Brugger, B. Kamber, W. Rittel, Helv. Chim. Acta 1970, 53, 2135-2150;
79. c) G. W. Anderson, J. E. Zimmerman, F. M. Callahan, J. Am. Chem. Soc. 1966, 88, 1338;
80. d) N. Izumiya, M. Muraoka, J. Am. Chem. Soc. 1969, 91, 2391.
81. [28].
82. [25a].
83. For selected examples of some related peptidyl hydantoins and peptidyl imminohydantoins, see: a) A. Boeijligen, R. M. J. Liskamp, Eur. J. Org. Chem. 1999, 2127-2135;
84. b) H. U. Stilz, W. Guba, B. Jablonka, M. Just, O. Klingler, W. Konig, V. Wehner, G. Zoller, J. Med. Chem. 2001, 44, 1158-1176;
85. c) G. Evindar, R. A. Batey, Org. Lett. 2003, 5, 1201-1204.
86. A. Boeijen, J. A. W. Kruijtzer, R. M. J. Liskamp, Bioorg. Med. Chem. Lett. 1998, 8, 2375-2380.
87. a) S. De Pol, C. Zorn, C. D. Klein, O. Zerbe, O. Reiser, Angew. Chem. Int. Ed. 2004, 43, 511-514;
88. b) A. Hayen, M. A. Schmitt, F. N. Ngassa, K. A. Thomasson, S. H. Gellman, Angew. Chem. Int. Ed. 2004, 43, 505-510;
89. c) M. A. Schmitt, B. Weisblum, S. H. Gellman, J. Am. Chem. Soc. 2004, 126, 6848-6849.
90. a) G. M. Loudon, M. R. Almond, J. N. Jacob, J. Am. Chem. Soc. 1981, 103, 4508-4515;
91. b) G. Moad, S. J. Benkovic, J. Am. Chem. Soc. 1978, 100, 5495-5499.
92. D. Valmori, J. F. Fonteneau, C. M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J. C. Cerottini, P. Romero, J. Immunol. 1998, 160, 1750-1758.
93. J. Neimark, J. P. Briand, Pept. Res. 1993, 6, 219-228.
94. It is worth mentioning that the excess of unreacted succinimidyl carbamate can be recovered at the end of the coupling procedure through standard liquid-phase extraction.
95. E. Kaiser, R. L. Colescott, C. D. Bossinger, P. I. Cook, Anal. Biochem. 1970, 34, 595-598.
96. [24]), there is no mention of a particular sensitivity of N-acyl-N′-carbamoyl- gem-diaminolalkyl moieties in ureidopeptides towards TFA-mediated hydrolysis.
97. K. Barlos, D. Gatos, J. Kallitsis, G. Papaphotiu, P. Sotiriu, Y. Wenging, W. Schäfer, Tetrahedron Lett. 1989, 30, 394-3946.
98. Z. Otwinowski, W. Minor, Methods Enzymology 1997, 276, 307-326 C. W. Carter Jr, R. M. Sweet, Eds., Academic Press (New York).
99. SIR92: A. Altomare, M. C. Burla, M. Camalli, G. Cascarano, C. Giacovazzo, A. Guagliardi, G. Polidori, J. Appl. Crystallogr. 1994, 27, 435-436.
100. G. M. Sheldrick, SHELXL97, An integrated system for solving and refining crystal structures from diffraction data. University of Göttingen, Germany, 1997.
101. L. J. Farrugia, J. Appl. Crystallogr. 1999, 32, 837-838.
102. L. J. Farrugia, J. Appl. Crystallogr. 1997, 30, 565.
103. WebLabViewer Pro 3.7, Molcular Simulations Inc., 2000.